Canadian firm IMRIS has secured 510(k) clearance from the FDA for its IMRISNV and IMRIScardio products. IMRISNV can generate MR images for use in evaluating the efficacy of therapies before, during and after the procedures, and IMRIScardio allows doctors to view a patient's cardiovascular system before, during and after a procedure.

Related Summaries